CRWEWallstreet.com Stock Report! 11/06/2009 MXWL, HDII, SBTB, TRMK, PWRM

_______________________________________

FREE Daily Stock Alerts From CRWEWallStreet.com

_______________________________________

David Schramm, president and chief executive officer of Maxwell Technologies, Inc. (Nasdaq: MXWL) will present at the Thomas Weisel Partners Alternative Energy & Natural Resources Conference at 3:15 p.m. (EST) on November 10, 2009 at the New York Palace Hotel.

Hypertension Diagnostics, Inc. (OTCBB: HDII), today announced financial results for the first quarter (Q1) of fiscal year 2010 ended September 30, 2009. Revenue for Q1 2010 totaled $302,075 compared to $136,512 for Q1 2009 ending September 30, 2008, which represents a 121% increase. While the Company incurred a net loss of $780,067 for Q1 2010 or $(.02) per share, compared with net income of $121,605 for Q1 2008, or $.00 per share, included in the net loss for Q1 2010 are total non-cash charges (deferred stock compensation, depreciation, stock options) of $788,190. Therefore, the Company was profitable in the quarter before non-cash charges.

SBT Bancorp, Inc. (OTCBB: SBTB), holding company for The Simsbury Bank & Trust Company, today announced third quarter 2009 net income of $160,000 and net income available to common shareholders of $95,000 or $0.11 per diluted share. This compares to a net loss of $1,556,000 or $1.80 per diluted share for the third quarter of 2008. For the nine months ended September 30, 2009, net income amounted to $527,000 and net income available to common shareholders equaled $395,000 or $0.46 per diluted share. This compares to a net loss of $931,000 or $1.09 per diluted share for the nine months ended September 30, 2008.

Trustmark Corporation (NASDAQ:TRMK) Chairman and CEO Richard G. Hickson will address analysts and investors attending the Sandler O'Neill & Partners, L.P., East Coast Financial Services Conference at The Ritz-Carlton, Palm Beach, Florida, Thursday, November 12, 2009 at 1:00 p.m. Eastern Time (12:00 p.m. Central Time).

Power3 Medical Products, Inc. (OTCBB: PWRM), a leader in neurodegenerative disease and cancer biomarkers and diagnostic tests, has announced further international recognition of validity as the company’s President and CSO, Dr. Ira Goldknopf, will deliver an invited Keynote address and chair a session on “Biomarkers and Diagnostics in Personalized Medicine (Track 6-4),” at the BIT Life Sciences 2nd International Congress and Expo of Molecular Diagnostics in Beijing, China, November 19-21, 2009. The Theme of the meeting is “New Leadership of Personalized Medicine.”

Web Site: http://www.Power3Medical.com

************Advertisement************

************************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB).